Real-world evidence for the effectiveness and breakthrough of BNT162b2 mRNA COVID-19 vaccine at a medical center in Japan일본 의료 센터에서 BNT162b2 mRNA COVID-19 백신의 효과 및 돌파구에 대한 실제 증거Article Published on 2022-12-312022-09-11 Journal: Human vaccines & immunotherapeutics [Category] COVID19(2023년), SARS, 변종, [키워드] Asia Asian BNT162b2 BNT162b2 vaccine breakthrough COVID-19 vaccine delta variant demonstrated Effectiveness Effectiveness. Evidence evidence of hospital hygiene Infection infection control Japan measure mRNA of BNT162b2 Population populations Public hygiene Regulation required retrospective cohort study SARS-CoV-2 Spread Tokyo vaccination Vaccine variant while [DOI] 10.1080/21645515.2021.1984124 PMC 바로가기 [Article Type] Article
Natural products from medicinal plants in Asia and the Pacific for RNA viruses: Hercules’ fifth labourArticle Published on 2022-12-012022-11-15 Journal: Pharmaceutical Biology [Category] 치료제, [키워드] active against analysis antiviral activity antiviral drug antiviral drugs Asia Asian ChemSpider Direct distribution Google Scholar Hercule hydroxytyrosol identify in vivo material molecular natural plant PubChem RNA RNA virus RNA virus Science Treatment viral genome replication viral infections virus virus Web of Science with COVID-19 zoonotic [DOI] 10.1080/13880209.2022.2130944 PMC 바로가기
Immunological responses following the third dose of the BNT162b2 SARS-CoV-2 vaccine among Japanese healthcare workersArticle Published on 2022-11-012022-11-15 Journal: Journal of infection and chemotherapy : official j [Category] COVID19(2023년), SARS, 진단, [키워드] age alcohol all age groups anti-RBD antibody antibody level antibody levels Antibody Response Antibody titer Asian baseline binding domain BNT162b2 BNT162b2 mRNA BNT162b2 vaccine Boosted vaccination booster dose booster vaccination conducted COVID-19 COVID-19 vaccine dose eight elevated Ethnic groups group healthcare worker Healthcare workers healthcare workers. healthy IgG information investigated Japan Japanese median median titer of BNT162b2 participant Prevent provided RBD response SARS-CoV-2 vaccine second dose serum shown significant increase the vaccine university vaccination Welfare [DOI] 10.1016/j.jiac.2022.07.006 PMC 바로가기
A prospective study of risk factors associated with seroprevalence of SARS-CoV-2 antibodies in healthcare workers at a large UK teaching hospitalArticle Published on 2022-11-012022-11-15 Journal: The Journal of Infection [Category] SARS, 진단, [키워드] 95% CI accounted age analysed Asian assistant Bame black conducted COVID-19 Factor Factors Fever group HCW HCWs healthcare healthcare worker Healthcare workers heterogeneous higher risk hospital immunoassay Increased increased risk independent multivariable model multivariate logistic regression positive Prospective Study reported risk risk factor risk factor analysis SARS-CoV-2 SARS-CoV-2 antibodies SARS-CoV-2 antibody SARS-COV-2 infection sense of taste sero-epidemiology. Seroprevalence Sex significantly significantly higher staff Symptom Symptoms tested [DOI] 10.1016/j.jinf.2022.08.030 PMC 바로가기
Racial and Ethnic Disparities in Outpatient Treatment of COVID-19 – United States, January-July 2022Article Published on 2022-10-282022-11-15 Journal: Morbidity and Mortality Weekly Report [Category] 치료제, [키워드] African American Alaska Antiviral Antiviral treatment antivirals Asian black booster doses Care COVID-19 COVID-19 in patient COVID-19 patient COVID-19 treatments COVID-19 vaccination disparity drug EHR Emergency use authorization EUA facilitate food Health help high risk highest Hispanic patient Immunocompromised less mAb medication Mild-to-moderate molnupiravir monoclonal antibody Native outcomes Outpatient Patient patient groups patients Paxlovid PROTECT Racial Remdesivir report risk seeking severe COVID-19 treated Treatment United States were used White patients [DOI] 10.15585/mmwr.mm7143a2 PMC 바로가기
Pre-Pandemic Cross-Reactive Immunity against SARS-CoV-2 among Central and West African PopulationsArticle Published on 2022-10-142022-11-15 Journal: Viruses [Category] COVID19(2023년), SARS, 진단, 치료기술, [키워드] Africa African antibody Antigen antigenic Asian blood donor collected control sample coronavirus 2 coronavirus disease-2019 COVID-19 COVID-19 pandemic CoviDiag detect evaluate France French highlighting human population Hypothesis identify IgG Immunity incidence rate investigated morbidity natural immunity neutralizing antibody original antigenic sin. pandemic Population pre-existing immunity Prevalence Protective Region reported respiratory SARS-CoV-2 SARS-CoV-2 protein sera statistically significant difference tested virus West [DOI] 10.3390/v14102259 PMC 바로가기
Analysis of 52 240 source plasma donors of convalescent COVID-19 plasma: Sex, ethnicity, and age association with initial antibody levels and rate of dissipationArticle Published on 2022-10-012022-11-15 Journal: Journal of clinical apheresis [Category] COVID19(2023년), SARS, 진단, [키워드] Abbott SARS-CoV-2 IgG African American age age and sex anti-SARS-CoV-2 antibody anti-SARS-CoV-2 titer antibody Antibody titer Antibody titers approved Asian association CCP convalescent convalescent COVID-19 plasma convalescent plasma COVID-19 Critically ill patient demographics donation Donor Efficacy elevated evaluate Evaluating Factor faster Frequency group help Hispanic hyperimmune hyperimmune globulins inclusion criteria individual initial lowest MOST Native nucleocapsid plasma plasma donor demographics. SARS-CoV-2 screened the United State therapy treat Variability was performed with COVID-19 [DOI] 10.1002/jca.21998 PMC 바로가기
The current status of thrombosis and anticoagulation therapy in patients with COVID-19 in Japan: From the CLOT-COVID studyObservational Study Published on 2022-10-012022-10-05 Journal: Journal of cardiology [Category] COVID19(2023년), SARS, 임상, [키워드] Anticoagulant Anticoagulants anticoagulation Asian bleeding Computed tomography coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 infection diagnosed with COVID-19 died disease dose enrolled hospital Hospitalization hospitalized patient incidence Japan Major management Mild Moderate COVID-19 multicenter cohort study occurred Patient patients with COVID-19 pharmacological Pneumonia polymerase chain positive proportion Respiratory failure retrospective severe COVID-19 severity the patient therapy Thromboprophylaxis thrombosis thrombosis. unmet need Venous Thromboembolism with COVID-19 [DOI] 10.1016/j.jjcc.2022.03.015 PMC 바로가기 [Article Type] Observational Study
Southeast Asian ovalocytosis detected in a critical patient with COVID-19 pneumoniaArticle Published on 2022-10-012022-11-15 Journal: International journal of laboratory hematology [Category] 진단, [키워드] Asian Critical ovalocytosis patient with COVID-19 Pneumonia [DOI] 10.1111/ijlh.13878 PMC 바로가기
Risk factors for developing COVID-19: a population-based longitudinal study (COVIDENCE UK)Article Published on 2022-09-012022-10-04 Journal: Thorax [Category] SARS, 임상, [키워드] 1.26 95% CI age allergic allergic lung disease Asian association Asthma asthma epidemiology atopic BMI body mass index Care clinical epidemiology. COVID-19 disease Epidemiology Factor Follow-up include Increased independent information logistic regression model lung Male sex Medical conditions obesity Older age participant population-based cohort potential risk questionnaire raised recorded registry SARS-CoV-2 severe COVID-19 Sex susceptibility [DOI] 10.1136/thoraxjnl-2021-217487 PMC 바로가기 [Article Type] Article